Cargando…
Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants
BACKGROUND: Infants born by caesarean section or receiving antibiotics are at increased risk of developing metabolic, inflammatory and immunological diseases, potentially due to disruption of normal gut microbiota at a critical developmental time window. We investigated whether probiotic supplementa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192119/ https://www.ncbi.nlm.nih.gov/pubmed/30326954 http://dx.doi.org/10.1186/s40168-018-0567-4 |
_version_ | 1783363844792385536 |
---|---|
author | Korpela, Katri Salonen, Anne Vepsäläinen, Outi Suomalainen, Marjo Kolmeder, Carolin Varjosalo, Markku Miettinen, Sini Kukkonen, Kaarina Savilahti, Erkki Kuitunen, Mikael de Vos, Willem M |
author_facet | Korpela, Katri Salonen, Anne Vepsäläinen, Outi Suomalainen, Marjo Kolmeder, Carolin Varjosalo, Markku Miettinen, Sini Kukkonen, Kaarina Savilahti, Erkki Kuitunen, Mikael de Vos, Willem M |
author_sort | Korpela, Katri |
collection | PubMed |
description | BACKGROUND: Infants born by caesarean section or receiving antibiotics are at increased risk of developing metabolic, inflammatory and immunological diseases, potentially due to disruption of normal gut microbiota at a critical developmental time window. We investigated whether probiotic supplementation could ameliorate the effects of antibiotic use or caesarean birth on infant microbiota in a double blind, placebo-controlled randomized clinical trial. Mothers were given a multispecies probiotic, consisting of Bifidobacterium breve Bb99 (Bp99 2 × 10(8) cfu) Propionibacterium freundenreichii subsp. shermanii JS (2 × 10(9)cfu), Lactobacillus rhamnosus Lc705 (5 × 10(9) cfu) and Lactobacillus rhamnosus GG (5 × 10(9) cfu) (N = 168 breastfed and 31 formula-fed), or placebo supplement (N = 201 breastfed and 22 formula-fed) during pregnancy, and the infants were given the same supplement. Faecal samples of the infants were collected at 3 months and analyzed using taxonomic, metagenomic and metaproteomic approaches. RESULTS: The probiotic supplement had a strong overall impact on the microbiota composition, but the effect depended on the infant’s diet. Only breastfed infants showed the expected increase in bifidobacteria and reduction in Proteobacteria and Clostridia. In the placebo group, both birth mode and antibiotic use were significantly associated with altered microbiota composition and function, particularly reduced Bifidobacterium abundance. In the probiotic group, the effects of antibiotics and birth mode were either completely eliminated or reduced. CONCLUSIONS: The results indicate that it is possible to correct undesired changes in microbiota composition and function caused by antibiotic treatments or caesarean birth by supplementing infants with a probiotic mixture together with at least partial breastfeeding. TRIAL REGISTRATION: clinicaltrials.gov NCT00298337. Registered March 2, 2006. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40168-018-0567-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6192119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61921192018-10-23 Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants Korpela, Katri Salonen, Anne Vepsäläinen, Outi Suomalainen, Marjo Kolmeder, Carolin Varjosalo, Markku Miettinen, Sini Kukkonen, Kaarina Savilahti, Erkki Kuitunen, Mikael de Vos, Willem M Microbiome Research BACKGROUND: Infants born by caesarean section or receiving antibiotics are at increased risk of developing metabolic, inflammatory and immunological diseases, potentially due to disruption of normal gut microbiota at a critical developmental time window. We investigated whether probiotic supplementation could ameliorate the effects of antibiotic use or caesarean birth on infant microbiota in a double blind, placebo-controlled randomized clinical trial. Mothers were given a multispecies probiotic, consisting of Bifidobacterium breve Bb99 (Bp99 2 × 10(8) cfu) Propionibacterium freundenreichii subsp. shermanii JS (2 × 10(9)cfu), Lactobacillus rhamnosus Lc705 (5 × 10(9) cfu) and Lactobacillus rhamnosus GG (5 × 10(9) cfu) (N = 168 breastfed and 31 formula-fed), or placebo supplement (N = 201 breastfed and 22 formula-fed) during pregnancy, and the infants were given the same supplement. Faecal samples of the infants were collected at 3 months and analyzed using taxonomic, metagenomic and metaproteomic approaches. RESULTS: The probiotic supplement had a strong overall impact on the microbiota composition, but the effect depended on the infant’s diet. Only breastfed infants showed the expected increase in bifidobacteria and reduction in Proteobacteria and Clostridia. In the placebo group, both birth mode and antibiotic use were significantly associated with altered microbiota composition and function, particularly reduced Bifidobacterium abundance. In the probiotic group, the effects of antibiotics and birth mode were either completely eliminated or reduced. CONCLUSIONS: The results indicate that it is possible to correct undesired changes in microbiota composition and function caused by antibiotic treatments or caesarean birth by supplementing infants with a probiotic mixture together with at least partial breastfeeding. TRIAL REGISTRATION: clinicaltrials.gov NCT00298337. Registered March 2, 2006. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40168-018-0567-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-16 /pmc/articles/PMC6192119/ /pubmed/30326954 http://dx.doi.org/10.1186/s40168-018-0567-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Korpela, Katri Salonen, Anne Vepsäläinen, Outi Suomalainen, Marjo Kolmeder, Carolin Varjosalo, Markku Miettinen, Sini Kukkonen, Kaarina Savilahti, Erkki Kuitunen, Mikael de Vos, Willem M Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants |
title | Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants |
title_full | Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants |
title_fullStr | Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants |
title_full_unstemmed | Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants |
title_short | Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants |
title_sort | probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192119/ https://www.ncbi.nlm.nih.gov/pubmed/30326954 http://dx.doi.org/10.1186/s40168-018-0567-4 |
work_keys_str_mv | AT korpelakatri probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT salonenanne probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT vepsalainenouti probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT suomalainenmarjo probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT kolmedercarolin probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT varjosalomarkku probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT miettinensini probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT kukkonenkaarina probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT savilahtierkki probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT kuitunenmikael probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants AT devoswillemm probioticsupplementationrestoresnormalmicrobiotacompositionandfunctioninantibiotictreatedandincaesareanborninfants |